Tango Therapeutics, Inc. (TNGX) Financials
TNGX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 435.8 million | 44.3 million |
| Dec. 31, 2025 | 398.7 million | 52.5 million |
| Sept. 30, 2025 | 210.1 million | 50.1 million |
| June 30, 2025 | 237.9 million | 102.9 million |
TNGX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -44.4 million | 10.8 million |
| Dec. 31, 2025 | -29.9 million | 6.0 million |
| Sept. 30, 2025 | -31.1 million | 6.6 million |
| June 30, 2025 | -37.1 million | 6.6 million |
TNGX Net Income
No data available :(
TNGX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 379.8 million | 30.0 million | - |
| Dec. 31, 2025 | 343.1 million | - | 30.8 million |
| Sept. 30, 2025 | 152.8 million | - | 34.8 million |
| June 30, 2025 | 180.8 million | - | 35.0 million |
TNGX Shares Outstanding
TNGX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 2000 | 33.1 million | 15.2 million | - |
| Dec. 31, 2025 | 222000 | 33.3 million | 9.8 million | - |
| Sept. 30, 2025 | 151000 | 30.8 million | 8.9 million | - |
| June 30, 2025 | 624000 | 32.2 million | 11.3 million | - |
TNGX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 463000 |
| Dec. 31, 2025 | - | 479000 |
| Sept. 30, 2025 | 53.8 million | 555000 |
| June 30, 2025 | 3.2 million | 625000 |
TNGX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
TNGX
Price: $32.90
52 week price:
Earnings Per Share: -0.83 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 179400
Market Capitalization: 2.6 billion